Chronic heart failure and type 2 diabetes mellitus: The last battle?

Diabetes and Vascular Disease Research

Volumn 12, Issue 4, 2015, Pages 226-227

  Kearney, Mark T ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID; GLUCOSE;

CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DEVICE THERAPY; DIABETIC CARDIOMYOPATHY; EDITORIAL; HEALTH CARE COST; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITY OF LIFE; SUDDEN CARDIAC DEATH; CARDIAC MUSCLE; DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS; DIASTOLIC HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MITOCHONDRION; HEART STROKE VOLUME; METABOLISM; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY;

DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; FATTY ACIDS; GLUCOSE; HEART FAILURE; HEART FAILURE, DIASTOLIC; HUMANS; MITOCHONDRIA, HEART; MYOCARDIUM; OXIDATIVE PHOSPHORYLATION; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84937000470     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164115590324     Document Type: Editorial

References (12)

1. Shah AD, Langenberg C, Rapsomaniki E,. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1-9 million people. Lancet Diabetes Endocrinol 2015; 3: 105-113.
2. Rosamond W, Flegal K, Furie K,. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-e146.
3. Cubbon RM, Adams B, Rajwani A,. Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology. Diab Vasc Dis Res 2013; 10: 330-336.
4. Kearney MT, Fox KA, Lee AJ,. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol 2002; 40: 1801-1808.
5. Bardy GH, Lee KL, Mark DB,. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237 (Erratum: N Engl J Med 2005; 352: 2146).
6. Shah AM, Mann DL,. In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet 2011; 378: 704-712.
7. Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 2012; 33: 1750-1757.
8. Cubbon RM, Gale CP, Kearney LC,. Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras. Circ Heart Fail 2011; 4: 396-403.
9. Cubbon RM, Woolston A, Adams B,. Prospective development and validation of a model to predict heart failure hospitalisation. Heart 2014; 100: 923-929.
10. Amaral N, Okonko DO., Metabolic abnormalities of the heart in type II diabetes. Diab Vasc Dis Res. Epub ahead of print 4 2015. DOI: 10.1177/1479164115580936.
11. Walker AMN, Cubbon RM,. Sudden cardiac death in patients with diabetes mellitus and chronic heart failure. Diab Vasc Dis Res. Epub ahead of print 10 2015. DOI: 10.1177/1479164115573225.
12. Lam CSP,. Diabetic cardiomyopathy: an expression of stage B heart failure with preserved ejection fraction. Diab Vasc Dis Res. Epub ahead of print 23 2015. DOI: 10.1177/1479164115579006.